These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3070082)

  • 21. Is CA 19-9 a screening marker?
    Barugola G; Frulloni L; Salvia R; Falconi M
    Dig Liver Dis; 2009 May; 41(5):325-7. PubMed ID: 19297258
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
    Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluid CEA in IPMNs: A useful test or the flip of a coin?
    Correa-Gallego C; Warshaw AL; Fernandez-del Castillo C
    Am J Gastroenterol; 2009 Mar; 104(3):796-7. PubMed ID: 19223886
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approach.
    Fabris C; Del Favero G; Basso D; Piccoli A; Meggiato T; Angonese C; Plebani M; Leandro G; Burlina A; Naccarato R
    Am J Gastroenterol; 1988 May; 83(5):549-53. PubMed ID: 3163228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor markers in the diagnosis of tumors in the subhepatic area].
    Dufek V; Petrtýl J; Klener P; Chmel J
    Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA19-9 and elastase-1 or ultrasonography.
    Homma T; Tsuchiya R
    Int J Pancreatol; 1991; 9():119-24. PubMed ID: 1744437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the galactose oxidase-Schiff's reagent sequence for early detection and prognosis in human colorectal adenocarcinoma.
    Carter JH; Deddens JA; Pullman JL; Colligan BM; Whiteley LO; Carter HW
    Clin Cancer Res; 1997 Sep; 3(9):1479-89. PubMed ID: 9815834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening tests for pancreatic cancer: searching for the early symptoms or the population at risk.
    Pezzilli R
    JOP; 2004 Jul; 5(4):240-2. PubMed ID: 15254357
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
    Jiang XT; Tao HQ; Zou SC
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two not-quite-Jurassic classics, and some mathematica prostatica.
    Kita MW
    J Insur Med; 1993; 25(3):368-77. PubMed ID: 10146435
    [No Abstract]   [Full Text] [Related]  

  • 31. A simple mucus test for cancer screening.
    Shamsuddin AM
    Anticancer Res; 1996; 16(4B):2193-9. PubMed ID: 8694542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tumor markers in gastrointestinal cancer and its clinical significance].
    Taguchi T; Ota J; Sumida S; Rii M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Usefulness of tumor markers of glycoprotein].
    Ishii M
    Rinsho Byori; 1988 Nov; Spec No 79():69-77. PubMed ID: 3249385
    [No Abstract]   [Full Text] [Related]  

  • 36. [Significance of glycolipid analysis in clinical tests].
    Senba U; Okabe H
    Nihon Rinsho; 1989 Dec; 48 Suppl():529-33. PubMed ID: 2516152
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
    Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
    Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The detection of laryngeal carcinoma-associated antigens in tissue and serum using three mixed monoclonal antibodies against laryngeal cancer].
    Chen O; Guan G; Jin C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(1):43-6. PubMed ID: 9275404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Early detection of pancreatic cancer by serum markers].
    Nakae Y; Naruse S; Shibata T; Kitagawa M; Kondo T; Hayakawa T; Kuno N; Kurimoto K
    Rinsho Byori; 1994 Feb; 42(2):139-42. PubMed ID: 7511183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor markers for pancreatic cancer: what happens when preoperative CA 19-9 is undetectable?
    Bouvet M
    Ann Surg Oncol; 2004 Jul; 11(7):637-8. PubMed ID: 15197009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.